Microspheres for controlled release drug delivery

Bibliography

• DATAMONITOR: Therapeutic Proteins: Strategic Market Analysis and Forecasts to 2010. (2002).
   Google Scholar
• NO AUTHORS LISTED: US Drug Delivery Systems Market- Emerging Technologies, Strategic Alliances, Patent Disputes, Market Size & Forecasts and R&D Activities. Fuji-Keizai, USA (2003).
   Google Scholar
• RAMDAS M, DEELIP KJ, ANITHA Y, PAUL W, SHARMA CP: Alginateencapsulated bioadhesive chitosan microspheres for intestinal drug delivery. Biomater. Appl. (1999) 13:290–296.
   PubMed Web of Science ®Google Scholar
• ARSHADY R: Preparation of microspheres and microcapsules by interfacial polycondensation techniques. Microencapsul (1989) 6:13–28.
   PubMed Web of Science ®Google Scholar
• BINDSCHAEDLER C, LEONG K, MATHIOWITZ E, LANGER R:Polyanhydride microsphere formulation by solvent extraction. Pharm. Sci. (1988) 77:696–698.
   PubMed Web of Science ®Google Scholar
• PONCELET D, BUGARSKI B, AMSDEN BG, ZHU J, NEUFELD R, GOOSEN MFA: A parallel plateelectrostatic droplet generator parameters affecting microbead size. Appl. Microbial. Biotechnol (1994) 42:251–255.
   Web of Science ®Google Scholar
• PAVANETTO F, GENTA I,GIUNCHEDI P, CONTI B: Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation. J. Microencapsul (1993) 10:487–497.
   PubMed Web of Science ®Google Scholar
• KAWASHIMA Y, NIWA T, HANDA T, TAKEUCHI H, IWAMOTO T, ITOH K: Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method. J. Pharm. Sri. (1989) 78:68–72.
   PubMed Web of Science ®Google Scholar
• ARSHADY R: Suspension, emulsion, anddispersion polymerisation: a methodological survey. Colloid Polymer Sri. (1992) 270:717–732.
   Web of Science ®Google Scholar
• KAMIYAMA M, KOYAMA K, MATSUDA H, SANO Y: Micron-sized polymeric microsphere by suspension polymerisation. J. Appl. Polymer Sci. (1993) 50:107–113.
   Web of Science ®Google Scholar
• SAHIN S, SELEK H, PONCHEL G et al: Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres. Control. Rel (2002) 82:345–358.
   PubMed Web of Science ®Google Scholar
• SINGH J, KARUNAKAR S, TRIPATHI KP: Preparation,characterization, and M vitro release kinetics of aminophylline-loaded albumin microspheres. Pharmazeutische Industrie (1994) 56:1076–1080.
   Web of Science ®Google Scholar
• KRIWET B, WALTER E, KISSEL T: Synthesis of bioadhesive poly (acrylic acid) nano- and microparticles using an inverse emulsion polymerisation method for the entrapment of hydrophilic drug candidates. J. Control. Rel. (1998) 56:149–158.
   PubMed Web of Science ®Google Scholar
• ZIMMER A: Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers. Methods (1999) 18:286–295.
   PubMed Web of Science ®Google Scholar
• RADWAN MA, ZAGHLOUL TY, ALY ZH: hi vivo performance of parenteral theophylline-loaded polyisobutylcyanoacrylate nanoparticles in rats. Eur.j Pharm. Sci. (1999) 8:95–98.
   PubMed Web of Science ®Google Scholar
• JAYACHANDRAN KN, CHATTERJI PR: Preparation of linear and crosslinked polymer microspheres by dispersion polymerisation. J. Macromol Sci. Polymer Rev (2001) C41:79–94.
   Google Scholar
• OWENS JL, ANSETH KS,RANDOLPH TW: Compressed antisolvent precipitation and photopolymerisation to form highly cross-linked polymer particles. Macromolecules (2002) 35:4289–4296.
   Web of Science ®Google Scholar
• CANELAS DA, DESIMONE JM: Polymerisations in liquid and supercritical carbon dioxide. Adv. Polymer Sci (1997) 133:103–140.
   Web of Science ®Google Scholar
• COHEN S, YOSHIOKA T, LUCARELLI M, HWANG LH, LANGER R: Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. (1991) 8:713–720.
   PubMed Web of Science ®Google Scholar
• MYLONAS CC, TABATA Y, LANGER R, ZOHAR Y: Preparation and evaluation of polyanhydride microspheres containing gonadotropin-releasing hormone (GnRH), for inducing ovulation and spermiation in fish. J. Control. Rel (1995) 35:23–34.
   Web of Science ®Google Scholar
• SAH H: Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres. I Pharm. Sci. Tech. (1999) 53:3–10.
   Google Scholar
• MA G, NAGAI M, ONT S: Preparation of uniform poly(lactide) microspheres by employing the Shirasu porous glass (SPG) emulsification technique. Colloids Surfacer A: Physicochem. Eng. Aspects (1999) 153:383–394.
   Web of Science ®Google Scholar
• HATATE Y, OHTA H, UEMURA Y, IJICHT K, YOSHIZAWA H: Preparation of monodispersed polymeric microspheres for toner particles by the Shirasu porous glass membrane emulsification technique. aAppl. Polymer Sc!. (1996) 64:1107–1113.
   Web of Science ®Google Scholar
• AMSDEN B: The production of uniformlysized polymer microspheres. Pharm. Res. (1999) 16:1140–1143.
   PubMed Web of Science ®Google Scholar
• BERKLAND C, KIM K, PACK DW: Fabrication of PLG microspheres with precisely controlled and monodisperse sizedistributions. I Control. Rel. (2001) 73:59–74.
   PubMed Web of Science ®Google Scholar
• SAVIC R, LUO L, EISENBERG A, MAYSINGER D: Micellar nanocontainers distribute to defined cytoplasmic organelles. Science (2003) 300:615–618.
   PubMed Web of Science ®Google Scholar
• OTSUKA H, NAGASAKI Y,KATAOKA K: PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Del. Rev (2003) 55:403–419.
   PubMed Web of Science ®Google Scholar
• DISCHER BM, WON YY, EGE DS et al.: Polymersomes: tough vesicles made from diblock copolymers. Science (1999) 284:1143–1146.
   PubMed Web of Science ®Google Scholar
• •This paper is one of the first reports on the formation of vesicles from arnphiphilic, diblock, polyethyleneoxide-polyethylethylene copolymers. These polymersomes are tougher and less permeable than commonphospholipid vesicles.
   Google Scholar
• DISCHER DE, EISENBERG A: Polymer vesicles. Science (2002) 297:967–973.
   PubMed Web of Science ®Google Scholar
• BROMBERG L, ALAKHOV V: Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell layers.j Control. Rel. (2003) 88:11–22.
   PubMed Web of Science ®Google Scholar
• VINOGRADOV SV, BRONICH TK, KABANOV AV: Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv. Drug Del. Rev (2002) 54:135–147.
   PubMed Web of Science ®Google Scholar
• KUMAR N, LANGER RS, DOMB AJ: Polyanhydrides: an overview. Adv. Drug Deliv. Rev (2002) 54:889–910.
   PubMed Web of Science ®Google Scholar
• •A thorough review of polyanhydride materials, including their synthesis, characterisation, and applications in drug delivery devices.
   Google Scholar
• TAMADA JA, LANGER R: Erosion kinetics of hydrolytically degradable polymers. Proc. Natl. Acad. Sci. USA (1993) 90:552–556.
   PubMed Web of Science ®Google Scholar
• O'DONNELL PB, MCGINITY JW: Preparation of microspheres by the solvent evaporation technique. Adv. Drug Deliv. Rev (1997) 28:25–42.
   PubMed Web of Science ®Google Scholar
• SALZMAN WM: Drug Delivery-Engineering Principles for Drug TherapySalzman WM (Ed.), Oxford University Press, New York (2001).
   Google Scholar
• ••This excellent book provides anengineering approach to pharmacokinetics, including the principles underlying drugtransport in the body, and design and construction of various types of drug delivery systems.
   Google Scholar
• GOPFERICH A, LANGER R: Modelingof polymer erosion. Macromolecules (1993) 26:4105–4112.
   Web of Science ®Google Scholar
• BURKERSRODA FV, SCHEDL L, GOPFERICH A: Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials (2002) 23:4221–4231.
   PubMed Web of Science ®Google Scholar
• ••This paper develops a theoretical model,incorporating water diffusivity inside a polymer matrix, the polymer degradation rate and the size of the polymer matrix, which predicts the erosion mechanism of the device. Interestingly, the paper shows that all degradable polymers, including polyesters and polyanhydrides, can undergo either bulk- or surface-erosion depending on the value of a dimensionless erosion number.
   Google Scholar
• ALONSO MJ, GUPTA RK, MIN C, SIBER GR, LANGER R: Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine (1994) 12:299–306.
   PubMed Web of Science ®Google Scholar
• LE CORRE P, LE GUEVELLO P, GAJAN V, CHEVANNE F, LE VERGE R: Preparation and characterization of bupivacaine-loaded polylactide and poly(lactide-glycolide) microspheres. Int. J. Pharm. (1994) 107:41–49.
   Web of Science ®Google Scholar
• MABUCHT K, NAKAYAMA A, IWAMOTO K: Preparation and in vitro evaluation of poly(lactic acid) microspheres containing carmofur. Yakuzaigaku (1994) 54:42–48.
   Google Scholar
• MEHTA RC, THANO0 BC, DELUCA PP: Peptide containing microspheres from low molecular weight and hydrophilic poly(d,l-lactide-co-glycolide). J. Control. Rel. (1996) 41:249–257.
   Web of Science ®Google Scholar
• BLANCO D, ALONSO MJ: Protein encapsulation and release from poly(lactide-co-glycolide) microspheres. Effect of the protein and polymer properties and of the co-encapsulation of surfactants. Ear: J. Pharm. Biopharm. (1998) 45:285–294.
   Google Scholar
• YAMAKAWA I, TSUSHIMA Y,MACHIDA R, WATANABE S: In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method. Pharm. Sri (1992) 81:808–811.
   PubMed Web of Science ®Google Scholar
• LIGGINS RT, BURT HM: Paclitaxel loaded poly(L-lactic acid) microspheres: properties of microspheres made with lowmolecular weight polymers. Int. J. Pharm (2001) 222:19–33.
   PubMed Web of Science ®Google Scholar
• KAWAGUCHI T, TSUGANE A, HIGASHIDE K et al.: Control of drug release with a combination of prodrug and polymer matrix: antitumor activity and release profiles of 2',3'-diacy1-5-fluoro-2'-deoxyuridine from poly(3-hydroxybutyrate) microspheres. Pharm. Sci. (1992) 81:508–512.
   PubMed Web of Science ®Google Scholar
• TABATA Y, LANGER R: Polyanhydride microspheres that display near-constant release of water-soluble model drug compounds. Pharm. Res. (1993) 10:391–399.
   PubMed Web of Science ®Google Scholar
• UN SY, CHEN KS, TENG HH, LI MJ: In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters. .1 Microencapsul (2000) 17:577–586.
   PubMed Web of Science ®Google Scholar
• SPENLEHAUER G, VERT M,BENOIT JP, BODDAERT A: In vitro and in vivo degradation of poly(DL-lactide/ glycolide) type microspheres made by solvent evaporation method. Biomaterials (1989) 10:557–563.
   PubMed Web of Science ®Google Scholar
• SHEN E, KIPPER MJ, DZIADUL B, LIM M-K, NARASIMHAN B: Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides. Control. Rel. (2002) 82:115–125.
   PubMed Web of Science ®Google Scholar
• KIPPER MJ, SHEN E, DETERMAN A, NARASIMHAN B: Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. Biomaterials (2002) 23:4405–4412.
   PubMed Web of Science ®Google Scholar
• PIGNATELLO R, FERRO M, PUGLISI G: Preparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylic polymers and studies on mechanisms of drug-polymer interactions. AAPS Pharm. Sci. Tech (2002) 3:1–11.
   Google Scholar
• GORACINOVA K, KLISAROVA L, SIMOV A, FREDRO-KUMBARADZI E, PETRUSEVSKA-TOZI L: Preparation, physical characterization, mechanisms of drug/polymer interactions, and stability studies of controlled-release solid dispersion granules containing weak base as active substance. Drug Dev. Ind. Pharm. (1996) 22:255–262.
   Web of Science ®Google Scholar
• ORIENTI I, BIGUCCI F,GENTILOMI G, ZECCHI V: Self-assembling poly(vinyl alcohol) derivatives,interactions with drugs and control of release. Pharm. Sci. (2001) 90:1435–1444.
   PubMed Web of Science ®Google Scholar
• NAGARAJAN R, GANESH K: Comparison of solubilization of hydrocarbons in (PEO-PPO) diblock versus (PEO-PPO-PEO) triblock copolymer micelles. Coll InL Sci. (1996) 184:489–499.
   PubMed Web of Science ®Google Scholar
• PLOEHN HJ, RUSSEL WB: Interactionsbetween colloidal particles and soluble polymers. Adv. Chem. Eng. (1990) 15:137–228.
   Google Scholar
• YANG YY, CHUNG TS, NG N: Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/ evaporation method. Biomaterials (2001) 22:231–241.
   PubMed Web of Science ®Google Scholar
• JAIN RA, RHODES CT, RAILKAR AM, MALICK AW, SHAH NH: Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables. Ear. I Pharm. Biopharm. (2000) 50:257–262.
   PubMed Web of Science ®Google Scholar
• FU K, PACK DW, KLIBANOV AM, LANGER R: Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res. (2000) 17:100–106.
   PubMed Web of Science ®Google Scholar
• •The authors report a novel method for visualisation of the chemical microclimate within degrading PLGA microspheres. The paper shows that accumulation of acidic degradation products can result in highly acidic environments at the core of sufficiently large microparticles.
   Google Scholar
• BERKLAND C, KIM K, PACK DW: PUG microsphere size controls drug release rate through several competing factors. Pharm. Res. (2003) 20:1055–1062.
   PubMed Web of Science ®Google Scholar
• BERKLAND C, KING M, COX A, KIM K, PACK D: Precise control of PUG microsphere size provides enhanced control of drug release rate. Control. Rel. (2002) 82:137–147.
   PubMed Web of Science ®Google Scholar
• YOUNG KR, ROSS TM: Particle-based vaccines for HIV-1 infection. Carr. Drug Targets: Infect. Dis. (2003) 3:151–169.
   Google Scholar
• THERMET A, ROLLIER C, ZOULIM F, TREPO C, COVA L: Progress in DNA vaccine for prophylaxis and therapy of hepatitis B. Vaccine (2003) 21:659–662.
   PubMed Web of Science ®Google Scholar
• FRIEDLANDER AM, WELKOS SL, IVINS BE: Anthrax vaccines. Carr. Top. Microbial. Immunol (2002) 271:33–60.
   PubMed Web of Science ®Google Scholar
• YU X-J, LUO C, LIN J-C et al.: Putative hAPN receptor binding sites in SARS_CoV spike protein. Acta Pharmacologica Sinica (2003) 24:481–488.
   PubMed Web of Science ®Google Scholar
• CLELAND JL: Single-administration vaccines: controlled-release technology to mimic repeated immunizations. Trends Biotech. (1999) 17:25–29.
   PubMed Web of Science ®Google Scholar
• KANE A, LLOYD J, ZAFFRAN M, SIMONSEN L, KANE M: Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull. World Health Organ. (1999) 77:801–807.
   PubMed Web of Science ®Google Scholar
• LOFTHOUSE S: Immunological aspects of controlled antigen delivery. Adv. Drug Deify. Rev (2002) 54:863–870.
   PubMed Web of Science ®Google Scholar
• SHI L, CAULFIELD MJ, CHERN RT et al.: Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. I Pharm. ScL (2002) 91:1019–1035.
   PubMed Web of Science ®Google Scholar
• CLELAND JL, LIM A, DAUGHERTY A et al.: Development of a single-shot subunit vaccine for HIV-1 with programmable in vivo autoboost and long-lasting neutralizing response. J. Pharm. Sci. (1998) 87:1489–1495.
   PubMed Web of Science ®Google Scholar
• SANCHEZ A, GUPTA RK, ALONSO MJ, SIBER GR, LANGER R: Pulsed controlled-release system for potential use in vaccine delivery. J. Pharm. ScL (1996) 85:547–552.
   PubMed Web of Science ®Google Scholar
• LEE HK, PARK JH, KWON KC: Double-walled microparticles for single shot vaccine. J. Control. Rel. (1997) 44:283–293.
   Web of Science ®Google Scholar
• SLOBBE L, MEDLICOTT N,LOCKHART E et at A prolonged immune response to antigen delivered in poly (epsilon-caprolactone) microparticles. Immunol Cell Biol. (2003) 81:185–191.
   PubMed Web of Science ®Google Scholar
• RAGHUVANSHI R, KATARE Y, LALWANI K et al.: Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants. Intl Pharm. (2002) 245:109–121.
   PubMed Web of Science ®Google Scholar
• CALVO P, REMUNAN-LOPEX C, VILA-JATO JL, ALONSO MJ: Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. (1997) 14:1431–1436.
   PubMed Web of Science ®Google Scholar
• HIGAKI M, AZECHI Y, TAKASE T et al.:Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid. Vaccine (2001) 19:3091–3096.
   PubMed Web of Science ®Google Scholar
• BARAS B, BENOIT MA, GILLARD J: Parameters influencing the antigen release from spray-dried poly(DL-lactide) microparticles. Int. Pharm. (2002) 200:133–145.
   Web of Science ®Google Scholar
• CLELAND JL: Solvent evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccines. Biotechnol. Frog. (1998) 14:102–107.
   Google Scholar
• STURESSON C, ARTURSSON P, GHADERI R et al.: Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres. Control. Rel. (1999) 59:377–389.
   PubMed Web of Science ®Google Scholar
• CHANG A, GUPTA RK: Stabilization of tetanus toxoid in poly(D,L-lactic-co-glycolic acid) microspheres for the controlled release of antigen. Pharm. ScL (1996) 85:129–132.
   PubMed Web of Science ®Google Scholar
• JIANG WS, STEVEN P: Stabilization of amodel formalinized protein antigen encapsulated in poly(lactide-co-glycolide)-based microspheres. Pharm. Sci. (2001) 90:1558–1569.
   PubMed Web of Science ®Google Scholar
• MOYNIHAN JS, BLAIR J, COOMBES A,D'MELLO F, HOWARD CR: Enhanced immunogenicity of a hepatitis B virus peptide vaccine using oligosaccharide ester derivative microparticles. Vaccine (2002) 20:1870–1876.
   PubMed Web of Science ®Google Scholar
• PURI N, KOU JH, SINKO PJ: Adjuvancyenhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres I. In vitro characterization. Control. Rel. (2000) 69:53–67.
   PubMed Web of Science ®Google Scholar
• PURI N, SINKO PJ: Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres II. hi vivo investigation. I Control. Rel. (2000) 69:69–80.
   PubMed Web of Science ®Google Scholar
• COOMBES A, MAJOR D, WOOD JM et al.: Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines. Biomaterials (1998) 19:1073–1081.
   PubMed Web of Science ®Google Scholar
• JABBAL-GILL I, UN W, JENKINS P et al.: Potential of polymeric lamellarsubstrate particles (PLSP) as adjuvants forvaccines. Vaccine (1999) 18:238–250.
   PubMed Web of Science ®Google Scholar
• POSTE G, KIRSCH R: Site-specific (targeted) drug delivery in cancer therapy. Bio/Technology (1983) 1:869–878.
   Google Scholar
• TABATA Y, IKADA Y: Phagocytosis of polymer microspheres by macrophages. Adv. Polymer Sci. (1990) 94:107–141.
   Web of Science ®Google Scholar
• BARROW ELW, WINCHESTER GA, STAAS JK, QUENELLE DC,BARROW WW: Use of microsphere technology for targeted delivery of rifampin to mycobacterium tuberculosis-infected macrophages. Antimicrob. Agents Chemother: (1998) 42:2682–2689.
   PubMed Web of Science ®Google Scholar
• RAMACHANDRA L, SONG R, HARDING CV: Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes. Immunol. (1999) 162:3263–3272.
   Web of Science ®Google Scholar
• NIXON DF, HIOE C, CHEN P-D et al:Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine (1996) 14:1523–1530.
   PubMed Web of Science ®Google Scholar
• WALSH MC, BANAS JA,MUDZINSKI SP et al.: A two-component modular approach for enhancing T-cell activation utilizing a unique anti-FcgRI-streptavidin construct and microspheres coated with biotinylated-antigen. Biomol. Eng. (2003) 20:21–33.
   Google Scholar
• CASTELLANOS IJ, CRUZ G, CRESPO R, GRIEBENOW K: Encapsulation-induced aggregation and loss in activity of y-chymotrypsin and their prevention. Control. Rel. (2002) 81:307–319.
   PubMed Web of Science ®Google Scholar
• FU K, GRIEBENOW K, HSIEH L, KLIBANOV AM, LANGER R: FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres. Control. Rel. (1999) 58:357–366.
   PubMed Web of Science ®Google Scholar
• •This paper describes the first analysis of protein secondary structure within the matrix of degrading PLGA microspheres.
   Google Scholar
• DIWAN M, PARK TG: Pegylation enhances protein stability during encapsulation in PLGA microspheres. J. Control. Rel. (2001) 73:233–244.
   PubMed Web of Science ®Google Scholar
• SCHWENDEMAN SP: Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Grit. Rev Ther. Drug Carrier Syst. (2002) 19:73–98.
   PubMed Web of Science ®Google Scholar
• ••An excellent review of recent literatureregarding various methods for stabilisingmacromolecular drugs inside controlled release devices, including a review of protein degradation mechanisms and a critical comparison of stabilisation approaches.
   Google Scholar
• LAM XM, DUENAS ET, CLELAND JL: Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. Pharm. Sci (2001) 90:1356–1365.
   PubMed Web of Science ®Google Scholar
• KING TW, PATRICK CW JR: Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/polyethylene glycol microspheres using a solid encapsulation/single emulsion/ solvent extraction technique. Biomed. Mater. Res. (2000) 51:383–390.
   PubMed Web of Science ®Google Scholar
• WOLF M, WIRTH M, PITTNER F, GABOR F: Stabilisation and determination of the biological activity of -asparaginase in poly(-lactide-co-glycolide) nanospheres. Int. J. Pharm. (2003) 256:141–152.
   PubMed Web of Science ®Google Scholar
• CLELAND JL, DUENAS ET, PARK A et al: Development of poly- (d,l-lactide-co-glycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. Control. Rel. (2001) 72:13–24.
   PubMed Web of Science ®Google Scholar
• STURESSON CC, J: Incorporation of protein in PLG microspheres with retention of bioactivity. Control. Rel. (2000) 67:171–178.
   PubMed Web of Science ®Google Scholar
• PEREZ-RODRIGUEZ C,MONTANO N, GONZALEZ K, GRIEBENOW K: Stabilization of a-chymotrypsin at the CH2C12/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres. Control. Rel. (2003) 89:71–85.
   PubMed Web of Science ®Google Scholar
• CASTELLANOS IJ, CRESPO R, GRIEBENOW K: Poly(ethylene glycol) as stabiliser and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. Control. Rel (2003) 88:135–145.
   PubMed Web of Science ®Google Scholar
• AL-AZZAM W, PASTRANA EA, GRIEBENOW K: Co-lyophilization of bovine serum albumin (BSA) with poly(ethylene glycol) improves efficiency of BSA encapsulation and stability in polyester microspheres by a solid-in-oil-in-oil technique. Biotechnol. Lett. (2002) 24:1367–1374.
   Web of Science ®Google Scholar
• JIANG W, SCHWENDEMAN SP: Stabilization and controlled release of bovine serum albumin encapsulated in poly(D, L-lactide) and poly(ethylene glycol) microsphere blends. Pharm. Res. (2001) 18:878–885.
   PubMed Web of Science ®Google Scholar
• ZHU X, LU L, CURRIER BL, WINDEBANK AJ, YASZEMSKI MJ: Controlled release of NFicB decoy oligonucleotides from biodegradable polymer microparticles. Biomaterials (2002) 23:2683–2692.
   PubMed Web of Science ®Google Scholar
• LU L, STAMATAS GN, MIKOS AG: Controlled release of transforming growth factor bl from biodegradable polymer microparticles..I. Biomed. Mater. Res. (2000) 50:440–451.
   PubMed Web of Science ®Google Scholar
• CLEEK RL, TING KC, G. ESKIN S, MIKOS AG: Microparticles of poly(-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery. J. Control. Rel. (1997) 48:259–268.
   Google Scholar
• PEREZ C, GRIEBENOW K: Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres. Biotechnol Bioeng. (2003) 82:825–832.
   PubMed Web of Science ®Google Scholar
• SHENDEROVA A, BURKE TG, SCHWENDEMAN SP: The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilises camptothecins. Pharm. Res. (1999) 16:241–248.
   PubMed Web of Science ®Google Scholar
• SHAO PG, BAILEY LC: Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres. Pharm. Dev. Tech. (1999) 4:633–642.
   PubMed Web of Science ®Google Scholar
• ZHU G, MALLERY SR,SCHWENDEMAN SP: Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Nat. Biotechnol (2000) 18:52–57.
   PubMed Web of Science ®Google Scholar
• ••This paper describes dramatic stabilisationof bovine serum albumin and basic fibroblast growth factor encapsulated within PLGA devices by co-incorporating Mg(OH)2 as an antacid to neutralise the acidic microenvironment caused by accumulation of acidic polymer degradation products.
   Google Scholar
• KANG J, SCHWENDEMAN SP: Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(d,l-lactide-co-glycolide) implants. Biomaterials (2001) 23:239–245.
   Web of Science ®Google Scholar
• ZHOU S, DENG X: ha vitro degradation characteristics of poly-lactide-poly(ethylene glycol) microspheres containing humanserum albumin. React. Funct. Polymers (2002) 51:93–100.
   Web of Science ®Google Scholar
• LIU Y, DENG X: Influences of preparation conditions on particle size and DNA-loading efficiency for poly(-lactic acid-polyethylene glycol) microspheres entrapping free DNA. I Control. Rel. (2002) 83:147–155.
   PubMed Web of Science ®Google Scholar
• LIM DW, PARK TG: Stereocomplex formation between enantiomeric PLA-PEG-PLA triblock copolymers: characterization and use as protein-delivery microparticulate carriers. J. Appl. Polymer ScL (2000) 75:1615–1623.
   Web of Science ®Google Scholar
• CHOI Y, KIM SY, KIM SH et al.: Long-term delivery of all-trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres. Int. J. Pharm. (2001) 215:67–81.
   PubMed Web of Science ®Google Scholar
• BITTNER B, WITT C, MADER K, KISSEL T: Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release. J. Control. Rel. (1999) 60:297–309.
   PubMed Web of Science ®Google Scholar
• MORLOCK M, KISSEL T, LI YX, KOLL H, WINTER G: Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. Control. Rel (1998) 56:105–115.
   PubMed Web of Science ®Google Scholar
• LI X, DENG X, YUAN M et at: In vitro degradation and release profiles of poly-DL-lactide-poly(ethylene glycol) microspheres with entrapped proteins. I Appl. Polymer ScL (2000) 78:140–148.
   Web of Science ®Google Scholar
• LI X, ZHANG Y, YAN R et al.: Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethylene glycol) microspheres. Control. Rel (2000) 68:41–52.
   PubMed Web of Science ®Google Scholar
• ZHOU SD, DENG X, YUAN M, LI X: Investigation on preparation and protein release of biodegradable polymer microspheres as drug-delivery system. Appl. Polymer ScL (2002) 84:778–784.
   Web of Science ®Google Scholar
• BAROUCH DH, SANTRA S,SCHMITZ JE et al.: Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science (2000) 290:486–492.
   Google Scholar
• DWARKI V, BELLONI P, NIJJAR T et al: Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII M vivo in mice. Proc. Nati Acad. Sci. USA (1995) 92:1023–1027.
   PubMed Web of Science ®Google Scholar
• HARTIGAN O CONNOR D, CHAMBERLAIN JS: Progress toward gene therapy of Duchenne muscular dystrophy. Semin. Neurol. (1999) 19:323–3332.
   PubMed Web of Science ®Google Scholar
• VILE RG, RUSSELL SJ, LEMOINE NR: Cancer gene therapy: hard lessons and new courses. Gene Ther. (2000) 7:2–8.
   PubMed Web of Science ®Google Scholar
• DONNELLY JJ, ULMER JB, SHIVER JVV, LIU MA: DNA vaccines. Anna. Rev Immunol (1997) 15:617–648.
   PubMed Web of Science ®Google Scholar
• VILE RG, TUSZYNSKI A,CASTLEDEN S: Retroviral vectors: from laboratory tools to molecular medicines. MM. Biotechnol (1996) 5:139–158.
   Google Scholar
• FELGNER PL, RINGOLD GM: Cationic liposome-mediated transfection. Nature (1989) 337:387–388.
   PubMed Web of Science ®Google Scholar
• MUMPER RJ, ROLLAND AP: Plasmid delivery to muscle: recent advances in polymer delivery systems. Adv. Drug Deify. Rev (1998) 30:151–172.
   PubMed Web of Science ®Google Scholar
• LEMIEUX P, VINOGRADOV SV, GEBHART CL et al.: Block and graft copolymers and NanoGel copolymer networks for DNA delivery into cells. J. Drug Target. (2000) 8:91–105.
   PubMed Web of Science ®Google Scholar
• LEMIEUX P, GUERIN N, PARADIS G et al.: A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene The]: (2000) 7:986–991.
   PubMed Web of Science ®Google Scholar
• WOLFF JA, MALONE RW, WILLIAMS P et al.: Direct gene transfer into mouse muscle M vivo. Science (1990) 247:1465–1468.
   PubMed Web of Science ®Google Scholar
• BUDKER V, ZHANG G, KNECHTLE S, WOLFF JA: Naked DNA delivered intraportally expresses efficiently in hepatocytes. Gene Thec (1996) 3:593–598.
   PubMed Web of Science ®Google Scholar
• FANG J, ZHU Y-Y, SMILEY E et al.: Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Nati Acad. ScL USA (1996) 93:5753–5758.
   PubMed Web of Science ®Google Scholar
• BONADIO J, GOLDSTEIN SA, LEVY RJ: Gene therapy for tissue repair and regeneration. Adv. Drug Deify. Rev (1998) 33:53–69.
   PubMed Web of Science ®Google Scholar
• LUO D, WOODROW-MUMFORD K, BELCHEVA N, SALTZMAN WM: Controlled DNA delivery systems. Pharm. Res. (1999) 16:1300–1308.
   PubMed Web of Science ®Google Scholar
• •This paper represents one of the first reports of plasmid DNA encapsulation 50and release from biodegradable polymer matrices.
   Google Scholar
• SHEA LD, SMILEY E, BONADIO J, MOONEY DJ: DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol (1999) 17:551–554.
   PubMed Web of Science ®Google Scholar
• •The authors report sustained release of plasmid DNA, encoding platelet-derived growth factor (PDGF), from a PLGA tissue-engineering matrix and the subsequent expression and biological activity of PDGF in cells both in vitro and in vivo.
   Google Scholar
• NOF M, SHEA LD: Drug-release scaffolds fabricated form drug-loaded microspheres. Biomed. Mater. Res. (2002) 59:349–356.
   PubMed Web of Science ®Google Scholar
• MATHIOWITZ E, JACOB JS, JONG YS et al: Biologically erodable microspheres as potential oral drug delivery systems. Nature (1997) 386:410–414.
   PubMed Web of Science ®Google Scholar
• ••This paper reports the first in vivoexpression of plasmid DNA delivered by encapsulation in polymer particles.
   Google Scholar
• HEDLEY ML, CURLEY J, URBAN R: Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat. Med. (1998) 4:365–368.
   PubMed Web of Science ®Google Scholar
• ••The authors report encapsulation ofplasmid DNA in PLGA microspheres that, following subcutaneous injection in mice, are passively targeted, based on their small size, to phagocytosis by professional antigen-presenting cells, and subsequently direct specific cytotoxic T cell responses to the encoded antigen.
   Google Scholar
• TINSLEY-BROWN AM, FRETWELL R, DOWSETT AB, DAVIS SL,FARRAR GH: Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. I Control. Rel. (2000) 66:229–241.
   PubMed Web of Science ®Google Scholar
• COHEN H, LEVY RJ, GAO J et al.: Sustained delivery and expression of DNAencapsulated in polymeric nanoparticles. Gene The]: (2000) 7:1896–1905.
   Google Scholar
• MAO H-Q, ROY K, WALSH SM, AUGUST JT, LEONG KW: DNA-chitosan nanospheres for gene delivery. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. (1996) 23:401–402.
   Google Scholar
• HIROSUE S, MULLER BG, MULLIGAN RC, LANGER R: Plasmid DNA encapsulation and release from solvent diffusion nanospheres. J. Control. Rel. (2001) 70:231–242.
   PubMed Web of Science ®Google Scholar
• LUNSFORD L, MCKEEVER U, ECKSTEIN V, HEDLEY ML: Tissue distribution and persistence in mice of plasmid DNA encapsulated in a PLGA-based microsphere delivery vehicle. .I. Drug Target. (2000) 8:39–50.
   PubMed Web of Science ®Google Scholar
• O'HAGAN D, SINGH M,UGOZZOLI M et al.: Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines. Virol. (2001) 75:9037–9043.
   Google Scholar
• WALTER E, DREHER D, KOK M et al.: Hydrophilic poly(dl-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells.' Control. Rel. (2001) 76:149–168.
   PubMed Web of Science ®Google Scholar
• SANG H, PISAREV VM, MUNGER C et al.: Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity. Vaccine (2003) 21:3019–3029.
   PubMed Web of Science ®Google Scholar
• LENGSFELD CS, ANCHORD O QUY TJ: Shear-induced degradation of plasmid DNA. J. Pharm. Sci. (2002) 91:1581–1589.
   PubMed Web of Science ®Google Scholar
• WANG D, ROBINSON DR, KWON GS, SAMUEL J: Encapsulation of plasmid DNA in biodegradable poly(d,l-lactic-co-glycolic acid) microspheres as a novelapproach for immunogene delivery. Control. Rel. (1999) 57:9–18.
   PubMed Web of Science ®Google Scholar
• WALTER E, MOELLING K,PAVLOVIC J, MERKLE HP: Microencapsulation of DNA using poly(-lactide-co-glycolide): stability issues and release characteristics. I Control. Rel (1999) 61:361–374.
   PubMed Web of Science ®Google Scholar
• ANDO S, PUTNAM D, PACK DW, LANGER R: PLGA Microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. Pharm. Se (1998) 88:126–130.
   Web of Science ®Google Scholar
• CAPAN Y, WOO BH, GEBREKIDAN S, AHMED S, DELUCA PP: Preparation and characterization of poly(DL-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA. Pharm. Res. (1999) 16:509–513.
   PubMed Web of Science ®Google Scholar
• CAPAN Y, WOO BH, GEBREKIDAN S, AHMED S, DELUCA PP: Influence of formulation parameters on the characteristics of poly(DL-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. Control. Rel. (1999) 60:279–286.
   PubMed Web of Science ®Google Scholar
• SEEMANN S, HAUFF P, SCHULTZE-MOSGAU M, LEHMANN C, RESZKA R: Pharmaceutical evaluation of gas-filled microparticles as gene delivery system. Pharm. Res. (2002) 19:250-257.Affiliation
   Google Scholar